home.aspx

 
. home.aspx home.aspx

ARCHIVED NEWS


    IN FIRST, CANCER DRUGS SIMULTANEOUSLY APPROVED IN US, CANADA, AUSTRALIA

    Sep 18, 2019

    Drug approvals often occur in succession, with pharmaceutical companies typically focusing first on top markets like the U.S. and Europe. Each country has different review procedures as well, at times resulting in delays for a drug cleared in, say, the U.S. to arrive elsewhere. Project Orbis, pilote...


    READ MORE

    /news-article.aspx?ID=34423442

    ACCELERON ABANDONS MUSCULAR DYSTROPHY DRUG

    Sep 18, 2019

    Acceleron has announced the discontinuation of the development of its drug intended for facioscapulohumeral muscular dystrophy (FSHD), ACE-083. The drug did not achieve statistically significant improvements in functional endpoints relative to placebo in a Phase II trial, which means that Acceleron ...


    READ MORE

    /news-article.aspx?ID=34433443

    J&J FINDS COMPETITIVE EDGE WITH LATEST ERLEADA APPROVAL

    Sep 18, 2019

    Generic competition is eating away at J&J's prostate cancer empire. Sales of Zytiga (abiraterone acetate) totaled $698 million in the second quarter, reflecting a 23% decline year over year. According to Iqvia data cited by SVB Leerink, J&J held 56% of the abiraterone acetate market for ...


    READ MORE

    /news-article.aspx?ID=34443444

    GENERICS OF OLDER DRUGS COULD HAVE SAVED MEDICARE BILLIONS, STUDY SAYS

    Sep 17, 2019

    Medicare and its beneficiaries could have saved an estimated $17.7 billion over a seven-year period on generic versions of older medicines instead of paying for newer, chemically similar but more expensive brand-name drugs, according to a study published in the Annals of Internal Medicine last month...


    READ MORE

    /news-article.aspx?ID=34353435

    EBOLA VACCINE FROM MERCK TAKES STEP TOWARD US APPROVAL

    Sep 17, 2019

    While Merck's Ebola vaccine isn't yet approved in the U.S. or Europe, the drugmaker has been providing extensive supplies of investigational doses at the request of the WHO. According to the company, Merck has shipped more than 245,000 1 milliliter doses of V920 to the international health a...


    READ MORE

    /news-article.aspx?ID=34363436

    MYMEDS&ME LAUNCH MOBILE DRUG SAFETY SITE

    Sep 17, 2019

    In time for World Patient Safety Day, MyMeds&Me has announced the launch of an “enhanced, intuitive, mobile-web version” of its safety reporting solution Reportum Public. The solution enables patients and healthcare professionals to report adverse events directly to marketing authori...


    READ MORE

    /news-article.aspx?ID=34373437

    THE CASE FOR A PUBLIC OPTION FOR THE DRUG INDUSTRY

    Sep 16, 2019

    Under siege from thousands of lawsuits from federal, state, and local governments for its role in the deadly opioid addiction crisis, drug manufacturer Purdue Pharma reached a tentative settlement with some of the plaintiffs last week. In the deal, Purdue would transform itself through the bankruptc...


    READ MORE

    /news-article.aspx?ID=34323432

    PHARMACEUTICAL PROCESS VALIDATION: PRODUCT QUALITY, SAFETY AND EFFICACY

    Sep 16, 2019

    Within pharmaceutical manufacturing, the goal of process validation is to build quality into the operation at every step. The result is consistent product quality. It seems straightforward but how does one achieve this when it involves a myriad of multiple systems (PLCs, HMIs, control systems, etc.)...


    READ MORE

    /news-article.aspx?ID=34333433

TRENDING NEWS


    COMBATTING SUPERBUGS WITH NANOCAPSULES

    Oct 18, 2019

    Scientists have uncovered a novel antibiotic-free approach that could help prevent and treat one of the most widespread bacterial pathogens, using nanocapsules made of natural ingredients.
    Helicobacter pylori (H. pylori) is a bacterial pathogen carried by 4.4 billion people worldwide, with th...


    READ MORE

    /news-article.aspx?ID=35023502

    THE FUTURE OF PHARMA: TECHNOLOGY'S OPPORTUNITY TO IMPROVE PATIENT CARE

    Oct 18, 2019

    Tech innovation is impacting everyone, everywhere — including those in need of specialty medical care. Although there has been robust innovation across the healthcare industry as a whole, patient services and engagement tools, specifically in pharma, are lagging behind. The idea that doctors c...


    READ MORE

    /news-article.aspx?ID=35033503

    IS THE US OPIOID LITIGATION NEARING AN END GAME?

    Oct 18, 2019

    Drugmakers, wholesalers and lawmakers in the US are said to be thrashing out the details of a big settlement – maybe as much as $50 billion – to settle thousands of lawsuits related to the US opioid crisis. The frenzied negotiations are taking place ahead of the start of the first federa...


    READ MORE

    /news-article.aspx?ID=35043504

    AI COULD WARN ABOUT DRUG INTERACTION SIDE EFFECTS

    Oct 17, 2019

    The more medications a patient takes, the greater the likelihood that interactions between those drugs could trigger negative side effects, including long-term organ damage and even death. Now, researchers at Penn State have developed a machine learning system that may be able to warn doctors and pa...


    READ MORE

    /news-article.aspx?ID=34993499

    TRACELINK: DIGITAL NETWORK PLATFORM TO FURTHER TRANSFORM THE GLOBAL PHARMACEUTICAL SUPPLY CHAIN

    Oct 17, 2019

    TraceLink, an integrated digital supply network, announces the launch of the Digital Network Platform. Built on top of the TraceLink Digital Supply Network, and designed for the rapid development of applications utilizing its multi-enterprise collaboration and data sharing capabilities, TraceLink&rs...


    READ MORE

    /news-article.aspx?ID=35003500

    THE BIOAVAILABILITY CHALLENGES FACING CBD MEDICINES

    Oct 17, 2019

    Cannabidiol, or CBD, is one of more than 100 different derivatives of Cannabis. CBD is produced from both synthetic and natural sources. It is non-psychotropic and is being increasingly promoted for its potential therapeutic benefits in pharmaceutical, nutraceutical, cosmetic, food and beverage appl...


    READ MORE

    /news-article.aspx?ID=35013501

    MUNDIPHARMA DEMONSTRATES SUPERIORITY OF NON-OPIOID PENTHROX IN RELIEVING PAIN

    Oct 16, 2019

    At the European Society of Emergency Medicine Congress, UK-based Mundipharma announced positive results from various trials of its analgesic Penthrox (methoxyflurane) for pain relief. Carried out in Italy, the MEDITA study demonstrated Penthrox was superior to standard analgesic treatment (SAT) &nda...


    READ MORE

    /news-article.aspx?ID=34963496

    INSILICO MEDICINE AND CHEMDIV FORM A STRATEGIC DRUG DISCOVERY SERVICE ALLIANCE

    Oct 16, 2019

    Insilico Medicine and ChemDiv, Inc. launched a new strategic collaboration to provide certain pharmaceutical and biotechnology companies with end-to-end drug discovery solutions. This collaboration combines the most advanced artificial intelligence (AI) techniques with a premium integrated drug disc...


    READ MORE

    /news-article.aspx?ID=34973497

    ACQUISITION IN THE PHARMA WORLD NOW A TREND?

    Oct 16, 2019

    The pharmaceutical companies have been acquiring new assets and subsidiaries in order to take over their research and intellectual property this has become a growing trend in the pharmaceutical world. Here’s a look at some new acquisitions in pharma. Alkem Laboratories Limited informed the mar...


    READ MORE

    /news-article.aspx?ID=34983498

    SANOFI OPENS DIGITAL MANUFACTURING FACILITY IN THE US

    Oct 15, 2019

    French pharmaceutical giant Sanofi has opened a digital manufacturing facility at Framingham in Massachusetts, the US for continuous production of biologics. The facility will use intensified technology to link the production process with research and development. The company expects the approach to...


    READ MORE

    /news-article.aspx?ID=34933493

    DEMENTIA PATIENTS DO BETTER WITHOUT DRUGS

    Oct 15, 2019

    An analysis of studies involving more than 23,000 people with dementia has found outdoor activities and massage are more effective than drugs in treating aggression and agitation. The authors, led by geriatrician Jennifer Watt from St. Michael's Hospital and the University of Toronto in Canada, ...


    READ MORE

    /news-article.aspx?ID=34943494

    PFIZER LAUNCHES ‘CATFISH’ COUNTERFEIT MEDICINES CAMPAIGN

    Oct 15, 2019

    Pfizer has announced the launch of a UK-wide campaign dubbed “Don’t be catfished by counterfeit medicines”. The campaign, which is targeted specifically at students, focuses mainly on Xanax (alprazolam), aiming to raise awareness amongst young people who are increasingly buying cou...


    READ MORE

    /news-article.aspx?ID=34953495

    COMBINATION OF TWO DRUGS DISRUPTS CANCER CELLS' ABILITY TO SURVIVE DNA DAMAGE, STUDY FINDS

    Oct 14, 2019

    In continuing efforts to find novel ways to kill cancer cells, researchers at the University of Maryland School of Medicine (UMSOM) have identified a new pathway that leads to the destruction of cancer cells. The new finding, recently published in the journal PNAS, could pave the way for the broader...


    READ MORE

    /news-article.aspx?ID=34903490

    IMAGINAB JOINS WITH AZ, PFIZER AND TAKEDA TO DEVELOP TUMOUR IMAGING TECH

    Oct 14, 2019

    LA-based biotech ImaginAb has signed a multi-party agreement with pharma giants AstraZeneca, Pfizer, and Takeda, for technology that allows scientists to see inside tumours, and monitor whether immunotherapies are taking effect. ImaginAb’s imaging technology targets and visualises CD8+ T cells...


    READ MORE

    /news-article.aspx?ID=34913491

    THE PHARMACEUTICAL SUPPLY CHAIN IS READY FOR BLOCKCHAIN

    Oct 14, 2019

    In pharmaceuticals and the life sciences sector, the most valuable commodity is trust. When a patient pops a pill, he is putting his life on the hands of the prescribing doctor and the drug company that developed the pill alongside the supply chain that delivered it to him. Now in drug production an...


    READ MORE

    /news-article.aspx?ID=34923492

    ROLE OF IOT IN THE PHARMA MANUFACTURING PROCESS

    Oct 11, 2019

    The latest technologies such as the Internet of Things (IoT) has attracted a vast majority of manufacturing companies to unlock its limitless potential. Pharmaceutical manufacturing companies are no exception. They have realized the potential of IoT in revolutionizing the manufacturing process from ...


    READ MORE

    /news-article.aspx?ID=34873487

SPOTLIGHT

When it comes to enlisting the cancer-fighting potential of the body’s immune defenses, Amgen believes versatility is a virtue. Dave Reese discusses Amgen’s growing cancer immunotherapy research capabilities. Large numbers of immune cells (T cells in particular) are frequently found within or adjace

RESOURCES

Events